Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion

被引:48
作者
Chakravorty, SJ [1 ]
Cockwell, P [1 ]
Girdlestone, J [1 ]
Brooks, CJ [1 ]
Savage, COS [1 ]
机构
[1] Univ Birmingham, Sch Med, MRC, Ctr Immune Regulat,Dept Anat, Birmingham B15 2TT, W Midlands, England
关键词
fractalkine; TNF-alpha; renal; epithelial cell; adhesion;
D O I
10.1046/j.1365-2249.2002.01906.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fractalkine (CX3 CL1) is a transmembrane molecule with a CX3 C chemokine domain attached to an extracellular mucin stalk which can induce both adhesion and migration of leucocytes. Mononuclear cell infiltration at renal tubular sites and associated tubular epithelial cell damage are key events during acute renal inflammation following renal allograft transplantation. Using northern and Western blot analysis, we have demonstrated the expression of fractalkine message and protein by renal tubular epithelial cells in vitro . The expression was up-regulated by TNF-alpha, a key proinflammatory cytokine in acute rejection. Investigation of surface expression of fractalkine on cultured proximal tubular epithelial cells revealed only a subpopulation of positively staining cells. Immunohistochemistry revealed that only a proportion of tubules in renal allograft biopsies showed induction of fractalkine expression. Studies using a static model of adhesion demonstrated CX3 CR1/fractalkine interactions accounted for 26% of monocytic THP-1 cell and 17% of peripheral blood natural killer cell adhesion to tubular epithelial cells, suggesting that fractalkine may have a functional role in leucocyte adhesion and retention, at selected tubular sites in acute renal inflammation. Thus, fractalkine blockade strategies could reduce mononuclear cell mediated tubular damage and improve graft survival following kidney transplantation.
引用
收藏
页码:150 / 159
页数:10
相关论文
共 48 条
  • [1] ACUTE KIDNEY GRAFT-REJECTION - A MORPHOLOGICAL AND IMMUNOHISTOLOGICAL STUDY ON ZERO-HOUR AND FOLLOW-UP BIOPSIES WITH SPECIAL EMPHASIS ON CELLULAR INFILTRATES AND ADHESION MOLECULES
    ANDERSEN, CB
    LADEFOGED, SD
    LARSEN, S
    [J]. APMIS, 1994, 102 (01) : 23 - 37
  • [2] A new class of membrane-bound chemokine with a CX(3)C motif
    Bazan, JF
    Bacon, KB
    Hardiman, G
    Wang, W
    Soo, K
    Rossi, D
    Greaves, DR
    Zlotnik, A
    Schall, TJ
    [J]. NATURE, 1997, 385 (6617) : 640 - 644
  • [3] Beck GC, 1999, CLIN EXP IMMUNOL, V118, P298
  • [4] T lymphocyte adhesion mechanisms within inflamed human kidney -: Studies with a Stamper-Woodruff assay
    Chakravorty, SJ
    Howie, AJ
    Cockwell, P
    Adu, D
    Savage, COS
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) : 503 - 514
  • [5] CHAN YL, 1984, J BIOL CHEM, V259, P224
  • [6] The role of fractalkine in the recruitment of monocytes to the endothelium
    Chapman, GA
    Moores, KE
    Gohil, J
    Berkhout, TA
    Patel, L
    Green, P
    Macphee, CH
    Stewart, BR
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 392 (03) : 189 - 195
  • [7] Chemoattraction of T cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines
    Cockwell, P
    Calderwood, JW
    Brooks, CJ
    Chakravorty, SJ
    Savage, COS
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (05) : 734 - 744
  • [8] Fractalkine expression in human renal inflammation
    Cockwell, P
    Chakravorty, SJ
    Girdlestone, J
    Savage, COS
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (01) : 85 - 90
  • [9] Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 -: Rapid communication
    Feng, LL
    Chen, SZ
    Garcia, GE
    Xia, YY
    Siani, MA
    Botti, P
    Wilson, CB
    Harrison, JK
    Bacon, KB
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (02) : 612 - 620
  • [10] Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow
    Fong, AM
    Robinson, LA
    Steeber, DA
    Tedder, TF
    Yoshie, O
    Imai, T
    Patel, DD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) : 1413 - 1419